Persistent inflammation alters the function of the endogenous brain stem cell compartment.

PubWeight™: 1.67‹?› | Rank: Top 3%

🔗 View Article (PMC 2570715)

Published in Brain on August 30, 2008

Authors

Stefano Pluchino1, Luca Muzio, Jaime Imitola, Michela Deleidi, Clara Alfaro-Cervello, Giuliana Salani, Cristina Porcheri, Elena Brambilla, Francesca Cavasinni, Andrea Bergamaschi, Jose Manuel Garcia-Verdugo, Giancarlo Comi, Samia J Khoury, Gianvito Martino

Author Affiliations

1: Neuroimmunology Unit, DIBIT, San Raffaele Scientific Institute, Milano, Italy.

Articles citing this

Neuroprotection and progenitor cell renewal in the injured adult murine retina requires healing monocyte-derived macrophages. J Exp Med (2011) 1.80

Cross-talk between neural stem cells and immune cells: the key to better brain repair? Nat Neurosci (2012) 1.55

Cyclooxygenase-1 is involved in the inhibition of hippocampal neurogenesis after lipopolysaccharide-induced neuroinflammation. Cell Cycle (2011) 1.54

Neural stem cells sustain natural killer cells that dictate recovery from brain inflammation. Nat Neurosci (2016) 1.48

Brain regeneration in physiology and pathology: the immune signature driving therapeutic plasticity of neural stem cells. Physiol Rev (2011) 1.40

Quiescence and activation of stem and precursor cell populations in the subependymal zone of the mammalian brain are associated with distinct cellular and extracellular matrix signals. J Neurosci (2010) 1.36

Stem cell transplantation in multiple sclerosis: current status and future prospects. Nat Rev Neurol (2010) 1.36

Long-term upregulation of inflammation and suppression of cell proliferation in the brain of adult rats exposed to traumatic brain injury using the controlled cortical impact model. PLoS One (2013) 1.33

Transplanted neural stem/precursor cells instruct phagocytes and reduce secondary tissue damage in the injured spinal cord. Brain (2012) 1.26

Extracellular vesicles from neural stem cells transfer IFN-γ via Ifngr1 to activate Stat1 signaling in target cells. Mol Cell (2014) 1.22

Reversible neural stem cell niche dysfunction in a model of multiple sclerosis. Ann Neurol (2011) 1.12

Determination of somatic and cancer stem cell self-renewing symmetric division rate using sphere assays. PLoS One (2011) 1.11

Plasticity of subventricular zone neuroprogenitors in MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) mouse model of Parkinson's disease involves cross talk between inflammatory and Wnt/β-catenin signaling pathways: functional consequences for neuroprotection and repair. J Neurosci (2012) 1.04

Inflammation-induced subventricular zone dysfunction leads to olfactory deficits in a targeted mouse model of multiple sclerosis. J Clin Invest (2011) 1.03

Animal Models of MS Reveal Multiple Roles of Microglia in Disease Pathogenesis. Neurol Res Int (2011) 1.00

Impaired neurogenesis in adult type-2 diabetic rats. Brain Res (2008) 0.98

Neurotrophin 3 transduction augments remyelinating and immunomodulatory capacity of neural stem cells. Mol Ther (2013) 0.98

PW1 gene/paternally expressed gene 3 (PW1/Peg3) identifies multiple adult stem and progenitor cell populations. Proc Natl Acad Sci U S A (2011) 0.96

The subependymal zone neurogenic niche: a beating heart in the centre of the brain: how plastic is adult neurogenesis? Opportunities for therapy and questions to be addressed. Brain (2009) 0.95

Uncovering novel actors in astrocyte-neuron crosstalk in Parkinson's disease: the Wnt/β-catenin signaling cascade as the common final pathway for neuroprotection and self-repair. Eur J Neurosci (2013) 0.95

Abrogated inflammatory response promotes neurogenesis in a murine model of Japanese encephalitis. PLoS One (2011) 0.94

Aging-induced Nrf2-ARE pathway disruption in the subventricular zone drives neurogenic impairment in parkinsonian mice via PI3K-Wnt/β-catenin dysregulation. J Neurosci (2013) 0.93

Angiogenesis in multiple sclerosis and experimental autoimmune encephalomyelitis. Acta Neuropathol Commun (2014) 0.92

Neurogenic and neuro-protective potential of a novel subpopulation of peripheral blood-derived CD133+ ABCG2+CXCR4+ mesenchymal stem cells: development of autologous cell-based therapeutics for traumatic brain injury. Stem Cell Res Ther (2013) 0.92

Cdk2 loss accelerates precursor differentiation and remyelination in the adult central nervous system. J Cell Biol (2011) 0.91

Neural stem cell niches in health and diseases. Curr Pharm Des (2012) 0.91

Neurogenic and non-neurogenic functions of endogenous neural stem cells. Front Neurosci (2014) 0.91

Molecular Mechanisms Mediating Retinal Reactive Gliosis Following Bone Marrow Mesenchymal Stem Cell Transplantation. Stem Cells (2015) 0.88

Activated microglia enhance neurogenesis via trypsinogen secretion. Proc Natl Acad Sci U S A (2013) 0.88

Opposite effect of inflammation on subventricular zone versus hippocampal precursors in brain injury. Ann Neurol (2011) 0.87

Neurogenic niches in the brain: help and hindrance of the barrier systems. Front Neurosci (2015) 0.86

Wnt/β-catenin signaling is required to rescue midbrain dopaminergic progenitors and promote neurorepair in ageing mouse model of Parkinson's disease. Stem Cells (2014) 0.86

Neural precursors exhibit distinctly different patterns of cell migration upon transplantation during either the acute or chronic phase of EAE: a serial MR imaging study. Magn Reson Med (2011) 0.85

Circulating endothelial progenitor cells: a new approach to anti-aging medicine? J Transl Med (2009) 0.84

Growth hormone responsive neural precursor cells reside within the adult mammalian brain. Sci Rep (2012) 0.84

Oct4-induced reprogramming is required for adult brain neural stem cell differentiation into midbrain dopaminergic neurons. PLoS One (2011) 0.84

Effects of inflammation on stem cells: together they strive? EMBO Rep (2015) 0.84

Age-related changes in astrocytic and ependymal cells of the subventricular zone. Glia (2014) 0.83

The subventricular zone is able to respond to a demyelinating lesion after localized radiation. Stem Cells (2014) 0.83

Influence of the extracellular matrix on endogenous and transplanted stem cells after brain damage. Front Cell Neurosci (2014) 0.83

Stem Cell-Based Tissue Replacement After Stroke: Factual Necessity or Notorious Fiction? Stroke (2015) 0.83

Dental follicle cells rescue the regenerative capacity of periodontal ligament stem cells in an inflammatory microenvironment. PLoS One (2014) 0.82

Accelerated repair of demyelinated CNS lesions in the absence of non-muscle myosin IIB. Glia (2014) 0.82

The aged brain: genesis and fate of residual progenitor cells in the subventricular zone. Front Cell Neurosci (2015) 0.82

In vivo fate analysis reveals the multipotent and self-renewal features of embryonic AspM expressing cells. PLoS One (2011) 0.81

Modulation of neural stem/progenitor cell proliferation during experimental Herpes Simplex encephalitis is mediated by differential FGF-2 expression in the adult brain. Neurobiol Dis (2013) 0.81

LINGO-1-Fc-Transduced Neural Stem Cells Are Effective Therapy for Chronic Stage Experimental Autoimmune Encephalomyelitis. Mol Neurobiol (2016) 0.80

Adiponectin receptor-mediated signaling ameliorates cerebral cell damage and regulates the neurogenesis of neural stem cells at high glucose concentrations: an in vivo and in vitro study. Cell Death Dis (2015) 0.80

Neural Stem Cells Engineered to Express Three Therapeutic Factors Mediate Recovery from Chronic Stage CNS Autoimmunity. Mol Ther (2016) 0.80

Subventricular zone microglia transcriptional networks. Brain Behav Immun (2010) 0.79

Regulation of oligodendrocyte progenitor cell maturation by PPARδ: effects on bone morphogenetic proteins. ASN Neuro (2010) 0.78

Cross-talk between human neural stem/progenitor cells and peripheral blood mononuclear cells in an allogeneic co-culture model. PLoS One (2015) 0.78

Analysis of neurogenesis during experimental autoimmune encephalomyelitis reveals pitfalls of bioluminescence imaging. PLoS One (2015) 0.78

Inflammation induced neurological handicap processes in multiple sclerosis: new insights from preclinical studies. J Neural Transm (Vienna) (2010) 0.78

Activated CD8+ T lymphocytes inhibit neural stem/progenitor cell proliferation: role of interferon-gamma. PLoS One (2014) 0.78

FSD-C10: A more promising novel ROCK inhibitor than Fasudil for treatment of CNS autoimmunity. Biosci Rep (2015) 0.77

Mental health, serum biomarkers and survival in severe COPD: a pilot study. Multidiscip Respir Med (2016) 0.77

Differential requirement of cyclin-dependent kinase 2 for oligodendrocyte progenitor cell proliferation and differentiation. Cell Div (2012) 0.77

Long Non-Coding RNA Expression during Aging in the Human Subependymal Zone. Front Neurol (2015) 0.77

Concise review: modeling multiple sclerosis with stem cell biological platforms: toward functional validation of cellular and molecular phenotypes in inflammation-induced neurodegeneration. Stem Cells Transl Med (2015) 0.76

Neural Stem Cell Transplantation Induces Stroke Recovery by Upregulating Glutamate Transporter GLT-1 in Astrocytes. J Neurosci (2016) 0.76

Taking Advantage of Nature's Gift: Can Endogenous Neural Stem Cells Improve Myelin Regeneration? Int J Mol Sci (2016) 0.76

New Concept of Neural Stem Cell Transplantation: Anti-inflammatory Role. Int J Stem Cells (2008) 0.76

Nutritional and Nanotechnological Modulators of Microglia. Front Immunol (2016) 0.75

Cyclooxygenase (COX)-1 takes control of adult hippocampal neurogenesis. Cell Cycle (2011) 0.75

Activation of Wnt signaling promotes hippocampal neurogenesis in experimental autoimmune encephalomyelitis. Mol Neurodegener (2016) 0.75

Nicotine modulates neurogenesis in the central canal during experimental autoimmune encephalomyelitis. Neuroscience (2015) 0.75

Metabolic determinants of the immune modulatory function of neural stem cells. J Neuroinflammation (2016) 0.75

Fibroblast Growth Factor-2 Enhanced The Recruitment of Progenitor Cells and Myelin Repair in Experimental Demyelination of Rat Hippocampal Formations. Cell J (2015) 0.75

Neurogenesis or non-neurogenesis: that is the question. J Clin Invest (2014) 0.75

Neural Stem Cell Plasticity: Advantages in Therapy for the Injured Central Nervous System. Front Cell Dev Biol (2017) 0.75

Articles cited by this

Generation of neurons and astrocytes from isolated cells of the adult mammalian central nervous system. Science (1992) 19.30

Subventricular zone astrocytes are neural stem cells in the adult mammalian brain. Cell (1999) 15.87

Inflammatory blockade restores adult hippocampal neurogenesis. Science (2003) 10.14

Cellular composition and three-dimensional organization of the subventricular germinal zone in the adult mammalian brain. J Neurosci (1997) 6.74

Hematopoietic stem cell gene transfer in a tumor-prone mouse model uncovers low genotoxicity of lentiviral vector integration. Nat Biotechnol (2006) 5.58

Neural stem cells in the adult mammalian forebrain: a relatively quiescent subpopulation of subependymal cells. Neuron (1994) 5.50

PDGFR alpha-positive B cells are neural stem cells in the adult SVZ that form glioma-like growths in response to increased PDGF signaling. Neuron (2006) 5.34

Injection of adult neurospheres induces recovery in a chronic model of multiple sclerosis. Nature (2003) 5.31

Neurogenesis in adult subventricular zone. J Neurosci (2002) 5.22

Origin of oligodendrocytes in the subventricular zone of the adult brain. J Neurosci (2006) 4.90

The glial identity of neural stem cells. Nat Neurosci (2003) 4.72

Becoming a new neuron in the adult olfactory bulb. Nat Neurosci (2003) 4.70

Immune cells contribute to the maintenance of neurogenesis and spatial learning abilities in adulthood. Nat Neurosci (2006) 4.30

Microglia activated by IL-4 or IFN-gamma differentially induce neurogenesis and oligodendrogenesis from adult stem/progenitor cells. Mol Cell Neurosci (2005) 3.77

Transcriptionally active Stat1 is required for the antiproliferative effects of both interferon alpha and interferon gamma. Proc Natl Acad Sci U S A (1996) 3.62

The therapeutic potential of neural stem cells. Nat Rev Neurosci (2006) 3.17

Evidence for stroke-induced neurogenesis in the human brain. Proc Natl Acad Sci U S A (2006) 2.55

Defining the actual sensitivity and specificity of the neurosphere assay in stem cell biology. Nat Methods (2006) 2.43

Enumeration of neural stem and progenitor cells in the neural colony-forming cell assay. Stem Cells (2008) 2.33

Further checkpoints in Th1 development. Immunity (2002) 2.31

Two types of astrocytes in cultures of developing rat white matter: differences in morphology, surface gangliosides, and growth characteristics. J Neurosci (1983) 2.18

Postmitotic death is the fate of constitutively proliferating cells in the subependymal layer of the adult mouse brain. J Neurosci (1992) 2.16

Area identity shifts in the early cerebral cortex of Emx2-/- mutant mice. Nat Neurosci (2000) 2.15

Experimental autoimmune encephalomyelitis mobilizes neural progenitors from the subventricular zone to undergo oligodendrogenesis in adult mice. Proc Natl Acad Sci U S A (2002) 2.10

In vivo clonal analyses reveal the properties of endogenous neural stem cell proliferation in the adult mammalian forebrain. Development (1998) 2.05

The adult mouse hippocampal progenitor is neurogenic but not a stem cell. J Neurosci (2005) 1.99

Time course and distribution of inflammatory and neurodegenerative events suggest structural bases for the pathogenesis of experimental autoimmune encephalomyelitis. J Comp Neurol (2007) 1.97

BUdR as an S-phase marker for quantitative studies of cytokinetic behaviour in the murine cerebral ventricular zone. J Neurocytol (1992) 1.78

Activation of the subventricular zone in multiple sclerosis: evidence for early glial progenitors. Proc Natl Acad Sci U S A (2007) 1.71

p21--negative regulator of the cell cycle. Proc Soc Exp Biol Med (1996) 1.61

Radial glial cell heterogeneity--the source of diverse progeny in the CNS. Prog Neurobiol (2007) 1.55

Stroke transiently increases subventricular zone cell division from asymmetric to symmetric and increases neuronal differentiation in the adult rat. J Neurosci (2004) 1.55

A new focal EAE model of cortical demyelination: multiple sclerosis-like lesions with rapid resolution of inflammation and extensive remyelination. Brain (2006) 1.35

Magnetic-resonance-based tracking and quantification of intravenously injected neural stem cell accumulation in the brains of mice with experimental multiple sclerosis. Stem Cells (2007) 1.27

Interferon-gamma inhibits cell cycle exit in differentiating oligodendrocyte progenitor cells. Glia (2005) 1.07

Proliferation and phenotype regulation in the subventricular zone during experimental allergic encephalomyelitis: in vivo evidence of a role for nerve growth factor. Proc Natl Acad Sci U S A (1998) 1.06

A mutually stimulating loop involving emx2 and canonical wnt signalling specifically promotes expansion of occipital cortex and hippocampus. Cereb Cortex (2005) 1.02

Glial cell lineages in the rat optic nerve. Cold Spring Harb Symp Quant Biol (1983) 0.87

Motor evoked potentials in a mouse model of chronic multiple sclerosis. Muscle Nerve (2006) 0.85

Articles by these authors

Oral fingolimod or intramuscular interferon for relapsing multiple sclerosis. N Engl J Med (2010) 13.82

Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. Nature (2011) 13.23

The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity. Nat Immunol (2005) 7.80

Oral fingolimod (FTY720) for relapsing multiple sclerosis. N Engl J Med (2006) 7.18

A specialized vascular niche for adult neural stem cells. Cell Stem Cell (2008) 5.53

PDGFR alpha-positive B cells are neural stem cells in the adult SVZ that form glioma-like growths in response to increased PDGF signaling. Neuron (2006) 5.34

Injection of adult neurospheres induces recovery in a chronic model of multiple sclerosis. Nature (2003) 5.31

Neurogenesis in adult subventricular zone. J Neurosci (2002) 5.22

EGF converts transit-amplifying neurogenic precursors in the adult brain into multipotent stem cells. Neuron (2002) 5.06

Randomized trial of oral teriflunomide for relapsing multiple sclerosis. N Engl J Med (2011) 4.93

Origin of oligodendrocytes in the subventricular zone of the adult brain. J Neurosci (2006) 4.90

Neural stem cells confer unique pinwheel architecture to the ventricular surface in neurogenic regions of the adult brain. Cell Stem Cell (2008) 4.90

Directed migration of neural stem cells to sites of CNS injury by the stromal cell-derived factor 1alpha/CXC chemokine receptor 4 pathway. Proc Natl Acad Sci U S A (2004) 4.70

Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis. Nat Genet (2013) 4.62

The programmed death-1 (PD-1) pathway regulates autoimmune diabetes in nonobese diabetic (NOD) mice. J Exp Med (2003) 4.20

A placebo-controlled trial of oral cladribine for relapsing multiple sclerosis. N Engl J Med (2010) 4.08

New neurons follow the flow of cerebrospinal fluid in the adult brain. Science (2006) 3.98

Microglia activated by IL-4 or IFN-gamma differentially induce neurogenesis and oligodendrogenesis from adult stem/progenitor cells. Mol Cell Neurosci (2005) 3.77

Infiltrating blood-derived macrophages are vital cells playing an anti-inflammatory role in recovery from spinal cord injury in mice. PLoS Med (2009) 3.68

Neurosphere-derived multipotent precursors promote neuroprotection by an immunomodulatory mechanism. Nature (2005) 3.53

Genome-wide meta-analysis identifies novel multiple sclerosis susceptibility loci. Ann Neurol (2011) 3.52

CD11b+Ly-6C(hi) suppressive monocytes in experimental autoimmune encephalomyelitis. J Immunol (2007) 3.39

250 microg or 500 microg interferon beta-1b versus 20 mg glatiramer acetate in relapsing-remitting multiple sclerosis: a prospective, randomised, multicentre study. Lancet Neurol (2009) 3.37

IL-9 induces differentiation of TH17 cells and enhances function of FoxP3+ natural regulatory T cells. Proc Natl Acad Sci U S A (2009) 3.31

Expression of Cux-1 and Cux-2 in the subventricular zone and upper layers II-IV of the cerebral cortex. J Comp Neurol (2004) 3.20

Comparison of fingolimod with interferon beta-1a in relapsing-remitting multiple sclerosis: a randomised extension of the TRANSFORMS study. Lancet Neurol (2011) 3.16

Critical role of the programmed death-1 (PD-1) pathway in regulation of experimental autoimmune encephalomyelitis. J Exp Med (2003) 3.00

Chromatin remodelling factor Mll1 is essential for neurogenesis from postnatal neural stem cells. Nature (2009) 2.87

Differentiated Parkinson patient-derived induced pluripotent stem cells grow in the adult rodent brain and reduce motor asymmetry in Parkinsonian rats. Proc Natl Acad Sci U S A (2010) 2.85

Antigen microarrays identify unique serum autoantibody signatures in clinical and pathologic subtypes of multiple sclerosis. Proc Natl Acad Sci U S A (2008) 2.57

Cellular composition and cytoarchitecture of the adult human subventricular zone: a niche of neural stem cells. J Comp Neurol (2006) 2.53

Galectin-1 deactivates classically activated microglia and protects from inflammation-induced neurodegeneration. Immunity (2012) 2.18

Localizing central nervous system immune surveillance: meningeal antigen-presenting cells activate T cells during experimental autoimmune encephalomyelitis. Ann Neurol (2009) 2.15

A critical role for the programmed death ligand 1 in fetomaternal tolerance. J Exp Med (2005) 2.13

Robust tumor immunity to melanoma mediated by interleukin-9-producing T cells. Nat Med (2012) 2.11

Reduction of seizures by transplantation of cortical GABAergic interneuron precursors into Kv1.1 mutant mice. Proc Natl Acad Sci U S A (2009) 2.06

Cortical adaptation in patients with MS: a cross-sectional functional MRI study of disease phenotypes. Lancet Neurol (2005) 2.01

Large-scale neuronal network dysfunction in relapsing-remitting multiple sclerosis. Neurology (2012) 2.00

Pharmacological rescue of mitochondrial deficits in iPSC-derived neural cells from patients with familial Parkinson's disease. Sci Transl Med (2012) 1.99

Mutations in ARFGEF2 implicate vesicle trafficking in neural progenitor proliferation and migration in the human cerebral cortex. Nat Genet (2003) 1.96

Human glioma growth is controlled by microRNA-10b. Cancer Res (2011) 1.96

Ofd1, a human disease gene, regulates the length and distal structure of centrioles. Dev Cell (2010) 1.94

Differential engagement of Tim-1 during activation can positively or negatively costimulate T cell expansion and effector function. J Exp Med (2007) 1.93

Interferon beta-1a for brain tissue loss in patients at presentation with syndromes suggestive of multiple sclerosis: a randomised, double-blind, placebo-controlled trial. Lancet (2004) 1.93

Delayed post-ischaemic neuroprotection following systemic neural stem cell transplantation involves multiple mechanisms. Brain (2009) 1.89

Transcriptional therapy with the histone deacetylase inhibitor trichostatin A ameliorates experimental autoimmune encephalomyelitis. J Neuroimmunol (2005) 1.89

Regulatory functions of CD8+CD28- T cells in an autoimmune disease model. J Clin Invest (2003) 1.76

Setting a research agenda for progressive multiple sclerosis: the International Collaborative on Progressive MS. Mult Scler (2012) 1.75

Epidermal growth factor induces the progeny of subventricular zone type B cells to migrate and differentiate into oligodendrocytes. Stem Cells (2009) 1.71

Association between pathological and MRI findings in multiple sclerosis. Lancet Neurol (2012) 1.70

Deep gray matter involvement on brain MRI scans is associated with clinical progression in multiple sclerosis. J Neuroimaging (2009) 1.70

Differentiation of human ES and Parkinson's disease iPS cells into ventral midbrain dopaminergic neurons requires a high activity form of SHH, FGF8a and specific regionalization by retinoic acid. Mol Cell Neurosci (2010) 1.69

Quantification of brain gray matter damage in different MS phenotypes by use of diffusion tensor MR imaging. AJNR Am J Neuroradiol (2002) 1.68

MicroRNA and mRNA expression profile screening in multiple sclerosis patients to unravel novel pathogenic steps and identify potential biomarkers. Neurosci Lett (2011) 1.64

Early hemorrhagic transformation of brain infarction: rate, predictive factors, and influence on clinical outcome: results of a prospective multicenter study. Stroke (2008) 1.63

Brain gray matter changes in migraine patients with T2-visible lesions: a 3-T MRI study. Stroke (2006) 1.63

Inflammation triggers synaptic alteration and degeneration in experimental autoimmune encephalomyelitis. J Neurosci (2009) 1.59

Autosomal dominant frontotemporal lobar degeneration due to the C9ORF72 hexanucleotide repeat expansion: late-onset psychotic clinical presentation. Biol Psychiatry (2013) 1.58

Neutralizing antibodies to interferon beta-1b multiple sclerosis: a clinico-radiographic paradox in the BEYOND trial. Mult Scler (2011) 1.57

Cross-talk between neural stem cells and immune cells: the key to better brain repair? Nat Neurosci (2012) 1.55

Differential role of programmed death-ligand 1 [corrected] and programmed death-ligand 2 [corrected] in regulating the susceptibility and chronic progression of experimental autoimmune encephalomyelitis. J Immunol (2006) 1.54

Comment on "Human neuroblasts migrate to the olfactory bulb via a lateral ventricular extension". Science (2007) 1.52

Thymidine analogs are transferred from prelabeled donor to host cells in the central nervous system after transplantation: a word of caution. Stem Cells (2005) 1.51

Evaluation of circulating osteopontin levels in an unselected cohort of patients with multiple sclerosis: relevance for biomarker development. Mult Scler (2013) 1.51

Brain network connectivity assessed using graph theory in frontotemporal dementia. Neurology (2013) 1.50

Synergy between immune cells and adult neural stem/progenitor cells promotes functional recovery from spinal cord injury. Proc Natl Acad Sci U S A (2006) 1.50

Weighing brain activity with the balance: Angelo Mosso's original manuscripts come to light. Brain (2013) 1.50

Age-dependent B cell autoimmunity to a myelin surface antigen in pediatric multiple sclerosis. J Immunol (2009) 1.50

Assessment of cardiac safety during fingolimod treatment initiation in a real-world relapsing multiple sclerosis population: a phase 3b, open-label study. J Neurol (2013) 1.47

Clinical relevance and functional consequences of the TNFRSF1A multiple sclerosis locus. Neurology (2013) 1.46

A reassessment of the plateauing relationship between T2 lesion load and disability in MS. Neurology (2009) 1.45

Intrinsically determined cell death of developing cortical interneurons. Nature (2012) 1.43

TGF-beta induces IL-9 production from human Th17 cells. J Immunol (2010) 1.40

Secondary progressive multiple sclerosis: current knowledge and future challenges. Lancet Neurol (2006) 1.40

Validation of diagnostic magnetic resonance imaging criteria for multiple sclerosis and response to interferon beta1a. Ann Neurol (2003) 1.39

Patent foramen ovale closure and brain ischaemic lesions. Heart (2013) 1.39

Migralepsy: a new case confirming the existence of this migraine complication and proposing therapy. Neurol Sci (2012) 1.39